These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 4042270)
21. Metabolomics and biochemical profiling in drug discovery and development. Watkins SM; German JB Curr Opin Mol Ther; 2002 Jun; 4(3):224-8. PubMed ID: 12139307 [TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms in drug-metabolizing enzymes and drug targets. Hiratsuka M; Mizugaki M Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011 [No Abstract] [Full Text] [Related]
23. Genetic and environmental factors affecting drug response in man. Vesell ES Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107 [No Abstract] [Full Text] [Related]
24. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Lynch T; Price A Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140 [TBL] [Abstract][Full Text] [Related]
29. Drugs and heredity. Pharmacogenetics--the study of heritable variations in drug response. Schimke RN J Kans Med Soc; 1969 Mar; 70(3):146-50. PubMed ID: 5773193 [No Abstract] [Full Text] [Related]
30. [Pharmacogenetics]. Mastrostefano MP; Di Pretoro L Acta Anaesthesiol; 1968; 19():Suppl 9:122+. PubMed ID: 5757550 [No Abstract] [Full Text] [Related]
31. Pharmacogenetics and therapeutic surveillance. Ann Biol Clin (Paris); 1985; 43(4):519-28. PubMed ID: 4091312 [No Abstract] [Full Text] [Related]
32. Pharmacogenomics: the genomics of drug response. March R Yeast; 2000 Apr; 17(1):16-21. PubMed ID: 10797598 [TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetic perspectives: genes, drugs and disease. Vesell ES Hepatology; 1984; 4(5):959-65. PubMed ID: 6434393 [No Abstract] [Full Text] [Related]
34. Genetic factors in drug therapy. Evans DA Sci Basis Med Annu Rev; 1969; ():166-82. PubMed ID: 4918368 [No Abstract] [Full Text] [Related]
35. [How are my receptors, doctor?]. Aarbakke J; Endresen PC Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1832-3. PubMed ID: 11464693 [No Abstract] [Full Text] [Related]
38. [Is chirality a key to stereoselective drug action?]. Cegła M; Duszyńska B Postepy Hig Med Dosw; 1990; 44(4-6):279-98. PubMed ID: 2097612 [TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype. Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551 [TBL] [Abstract][Full Text] [Related]
40. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF; Liu JP; Chowbay B Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]